Pinealon
CognitiveKhavinson pineal tripeptide / researchExperimental
Glu-Asp-Arg tripeptide from the Khavinson pineal series, studied for neuroprotection in older literature. Not FDA-approved.
For research use only.
Key Facts
- CAS
- 175337-90-3
- Molecular Weight (MW)
- 450.41 g/mol
- Half-life
- Not established in humans
- Unit
- mcg
- Administration Route
- —
- Frequency
- —
- Last updated
- 8/23/2026
- Targets
- CNS / pineal (proposed)
Overview
Glu-Asp-Arg tripeptide from the Khavinson pineal series, studied for neuroprotection in older literature. Not FDA-approved.
Protocol
- Dosage Range
- Not established for FDA-approved use
- Frequency
- —
- Cycle
- —
- Administration Route
- —
- Reconstitution Guide
- —
Science
Mechanism of Action
Claimed to reduce oxidative neuronal injury and support pineal/CNS protein synthesis in Russian papers. Not confirmed in large RCTs.
Targets
CNS / pineal (proposed)
Studies
- Pinealon / EDR peptide literature— Journal/year not available
Benefits
Neuroprotection research (historical)
Potential Side Effects
- Not well characterized
References
- PMID 22616017External link · Year —